Skip to main content
A Singapore Government Agency Website How to identify
Official website links end with .gov.sg
Government agencies communicate via .gov.sg websites (e.g. go.gov.sg/open). Trusted websites
Secure websites use HTTPS
Look for a lock () or https:// as an added precaution. Share sensitive information only on official, secure websites.

Government officials will never ask you to transfer money or disclose bank log-in details over a phone call.

Call the 24/7 ScamShield Helpline at 1799 if you are unsure if something is a scam.

National Drug Formulary

INFANRIX IPV+HIB VACCINE [SIN10988P]

Active ingredients: DIPHTHERIA TOXOID (D) | FILAMENTOUS HAEMAGGLUTININ (FHA) | HIB PURIFIED CAPSULAR POLYSACCHARIDE | PERTACTIN (PRN OR 69KDA OUTER MEMBRANE PROTEIN) | PERTUSSIS TOXOID (PT) | POLIO VIRUS TYPE 1 (INACTIVATED) | POLIO VIRUS TYPE 2 (INACTIVATED) | POLIO VIRUS TYPE 3 (INACTIVATED) | TETANUS TOXOID (T)

View product's general information
Last updated 28 July 2026

Product Info

INFANRIX IPV+HIB VACCINE

[SIN10988P]

Product information

Active Ingredient and Strength

DIPHTHERIA TOXOID (D) - MIN 30 INTERNATIONAL UNITS/0.5 ML
FILAMENTOUS HAEMAGGLUTININ (FHA) - 25 MCG/0.5 ML
HIB PURIFIED CAPSULAR POLYSACCHARIDE - 10 MCG/0.5 ML
PERTACTIN (PRN OR 69KDA OUTER MEMBRANE PROTEIN) - 8 MCG/0.5 ML
PERTUSSIS TOXOID (PT) - 25 MCG/0.5 ML
POLIO VIRUS TYPE 1 (INACTIVATED) - 40 DU/0.5 ML
POLIO VIRUS TYPE 2 (INACTIVATED) - 8 DU/0.5 ML
POLIO VIRUS TYPE 3 (INACTIVATED) - 32 DU/0.5 ML
TETANUS TOXOID (T) - MIN 40 INTERNATIONAL UNITS/0.5 ML

Dosage Form

INJECTION

Manufacturer and Country

GLAXOSMITHKLINE BIOLOGICALS - FRANCE
GLAXOSMITHKLINE BIOLOGICALS SA - BELGIUM

Registration Number

SIN10988P

Licence Holder

GLAXOSMITHKLINE PTE LTD

Forensic Classification

PRESCRIPTION ONLY MEDICINES

Anatomical Therapeutic Chemical (ATC) code

J07CA06

Prescription-only Medicines with Exemptions for Supply without Prescription

NA

Indication

Indications

Infanrix-IPV+Hib is indicated for active immunisation in infants from the age of 2 months against diphtheria, tetanus, pertussis, poliomyelitis and Haemophilus influenzae type b.

Infanrix-IPV+Hib is also indicated as a booster dose for children who have previously been immunised with diphtheria, tetanus, pertussis (DTP), polio and Hib antigens.

Infanrix-IPV+Hib does not protect against diseases caused by other types of Haemophilus influenzae nor against meningitis caused by other organisms.

Dosing

Dosage and Administration

Posology

The primary vaccination schedule consists of three doses in the first 6 months of life and can start from the age of 2 months. An interval of at least 1 month should be maintained between subsequent doses.

A booster dose is recommended in the second year of life, with an interval of at least 6 months after completion of primary vaccination schedule.

Method of administration

Infanrix-IPV+Hib is for deep intramuscular injection, in the anterolateral thigh.

It is preferable that each subsequent dose is given at alternate sites.

Infanrix-IPV+Hib should be administered with caution to subjects with thrombocytopenia or a bleeding disorder since bleeding may occur following an intramuscular administration to these subjects. Firm pressure should be applied to the injection site (without rubbing) for at least two minutes.

Contraindications

Contraindications

Infanrix-IPV+Hib should not be administered to subjects with known hypersensitivity to any component of the vaccine, or to subjects having shown signs of hypersensitivity after previous administration of diphtheria, tetanus, pertussis, inactivated polio or Hib vaccines.

Infanrix-IPV+Hib is contraindicated if the child has experienced an encephalopathy of unknown aetiology, occurring within 7 days following previous vaccination with pertussis-containing vaccine.